Why the study?
Primary cardiac lymphomas are rare, have sudden onset, rapid progression, and high mortality, necessitating detailed clinical and pathological characterization.
Case Report (n=1)
No
Primary cardiac diffuse large B-cell lymphoma is a rare, aggressive malignancy that can present as heart failure and carries a poor prognosis despite surgical resection and chemotherapy.
Answers are grounded in this paper and cite their sources.
Documents rare primary cardiac DLBCL presentation; extends sparse case literature but leaves optimal management strategies open.
Primary cardiac lymphomas display a low frequency, sudden onset, swift progression of illness and elevated mortality rates. The current study presents a unique instance of primary cardiac diffuse large B‑cell lymphoma and examines its clinical manifestations, pathological characteristics and differential diagnosis. A 64‑year‑old male patient sought medical attention due to cardiac debility and exertional dyspnea persisting for >10 days. Chest enhanced computed tomography revealed a moderately enhancing irregular mass in the ventricular area, exhibiting limited demarcation from the pericardium and left atrium, accompanied by irregular thickening of the interventricular septum. The postoperative specimen showed the presence of yellow fish‑like tumor tissue. Immunohistochemical analysis revealed the presence of lymphocytes positive for CD20, BCL‑2, BCL‑6, c‑Myc‑binding protein, mutated melanoma‑associated antigen 1 and CD79a, along with a high Ki‑67 proliferation index of 80%. Conversely, CD10, CD30, CD3, pan cytokeratin, cyclin D1, desmin and vimentin marker results were found to be negative. Additionally, in situ hybridization demonstrated a lack of Epstein‑Barr virus‑encoded small RNA expression. The present case report emphasizes the significance of conducting a thorough analysis of the clinical manifestations of diffuse large B‑cell lymphoma to assist clinicians in establishing a diagnosis and determining an effective treatment approach, thereby enhancing the patient's prognosis.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2023) conducted a case report in Primary cardiac diffuse large B-cell lymphoma (n=1). Surgical resection and R-CHOP chemotherapy was evaluated on Clinical outcome.
Synapse has enriched 10 related papers. Consider them for comparative context: